Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.

Infection and Immunity
R D DixJ R Baringer


Monoclonal antibodies HCl and HD1, directed against herpes simplex virus type 1 (HSV-1) glycoproteins gC and gD, respectively, were evaluated for their ability to passively immunize mice against acute virus-induced neurological disease after footpad inoculation with HSV-1 or herpes simplex virus type 2 (HSV-2). Control virus-infected mice receiving a single intraperitoneal injection of normal serum died within 7 to 10 days after the spread of virus from footpad to spinal cord and brain. However, a single intraperitoneal injection of either HCl or HD1 antibody protected mice from neurological illness and death when administered to HSV-1 (strain HTZ)-infected mice at either 2 h before virus challenge or at 24 h after virus inoculation. To determine the in vivo specificity of the antibodies, passive transfer studies were performed with mice infected with the MP strain of HSV-1, a mutant of HSV-1 (mP) which is defective in the production of glycoprotein gC. Whereas HD1 antibody decreased the incidence of neurological illness in MP- and mP-infected mice, HCl antibody, which protected mP-infected animals, failed to protect mice infected with the MP strain. When HD1 antibody was administered to HSV-2 (strain G)-infected mice at either...Continue Reading


Sep 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·R ManservigiA Buchan
Aug 1, 1978·Infection and Immunity·J E Oakes, H Rosemond-Hornbeak
Jan 1, 1971·Acta Neuropathologica·K KristenssonJ Sjöstrand
Aug 1, 1980·Infection and Immunity·L PereiraJ R Baringer
Aug 12, 1965·The New England Journal of Medicine·W LEIDERL N R LEONARDS

❮ Previous
Next ❯


Oct 1, 1984·European Journal of Clinical Microbiology·R A Polin
May 1, 1994·Veterinary Pathology·E B BelknapP C Schultheiss
Jul 11, 2006·Folia Microbiologica·J Rajcáni, V Durmanová
Jan 1, 1992·Archives of Virology·M ErturkR Jennings
Apr 1, 1991·FEMS Microbiology Immunology·S Welling-WebsterG W Welling
Dec 1, 1988·FEMS Microbiology Immunology·M J WelchR J Phillpotts
Mar 13, 1986·The New England Journal of Medicine·L Corey, P G Spear
Apr 1, 1992·Journal of Medical Virology·S L FowlerL R Stanberry
Oct 4, 1984·The New England Journal of Medicine·N C Engleberg, B I Eisenstein
Oct 14, 2005·Expert Review of Vaccines·David Bernstein
Jul 4, 2012·Viruses·Roselyn J EisenbergGary H Cohen
Feb 27, 2013·Reviews in Medical Virology·Thessicar E AntoineDeepak Shukla
Feb 5, 2021·Frontiers in Cellular and Infection Microbiology·Krishnaraju MadavarajuDeepak Shukla
Dec 21, 2010·The Journal of Allergy and Clinical Immunology·Larry BorishCharles H Kirkpatrick
May 1, 1989·Journal of Virology·V J IsolaG H Cohen

❮ Previous
Next ❯